Evidence map›Paper›PMID 34868706›Full record

ArticleFood science and biotechnology2021

Antihypertriglyceridemia activities of naturally fermented green tea, Heukcha, extract through modulation of lipid metabolism in rats fed a high-fructose diet.

Hyun Woo Jeong, Ji-Hae Lee, Jin Kyu Choi, Chan-Su Rha, Jung Dae Lee, Jaehong Park, Miyoung Park

Open access · greenAbstract read
In one paragraph

Article in Food science and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hyun Woo JeongHealthcare Research Division, AMOREPACIFIC R&D Center, Yongin, Republic of Korea.
Ji-Hae LeeHealthcare Research Division, AMOREPACIFIC R&D Center, Yongin, Republic of Korea.
Jin Kyu ChoiQA Team, Aestura Corporation, Ansung, Republic of Korea.
Chan-Su RhaHealthcare Research Division, AMOREPACIFIC R&D Center, Yongin, Republic of Korea.
Jung Dae LeeOsulloc R&D Center, Osulloc Farm Corporation, Jeju, Republic of Korea.
Jaehong ParkHealthcare Research Division, AMOREPACIFIC R&D Center, Yongin, Republic of Korea.
Miyoung ParkHealthcare Research Division, AMOREPACIFIC R&D Center, Yongin, Republic of Korea.
Amorepacific (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertriglyceridemia, a symptom of elevated triglyceride level in the blood, is a potent risk factor for cardiovascular and metabolic disorders. Among the numerous treatments to regulate circulating triglyceride levels, fibrates are widely used to treat hypertriglyceridemia, although they also have side effects such as hepatotoxicity and gallstone formation. In the present study, we aimed to investigate the blood triglyceride-lowering effects of a naturally fermented green tea extract (NFGT) and the underlying mechanisms on hypertriglyceridemia in vitro and in vivo models. NFGT suppressed the expression of lipogenic genes, while augmented expression of fatty acid oxidation-related genes in cultured cells, leading to the significant decrease of intracellular triglyceride content. NFGT treated group in fructose-induced hypertriglyceridemic rat model significantly decreased plasma and hepatic triglyceride, which was accompanied by an increase in excretion of fecal fat. Taken together, we propose that NFGT could be potentially a novel functional ingredient to prevent or treat hypertriglyceridemia.

Indexed as

HypertriglyceridemiaLipid metabolismNaturally fermented green teaPancreatic lipase

Identifiers

PMID34868706
PMCPMC8595438
OpenAlexW3208754835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.